World's First Malaria Vaccine Gets Green Light From EU Drug Regulators

The shot, called RTS,S or Mosquirix and developed by British drugmaker GlaxoSmithKlinein partnership with the PATH Malaria Vaccine Initiative, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria in countries that use it.